12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
08.12.2016
- Swiss specialty chemicals and biologics producer Lonza has agreed to sell its peptides business and operations in Braine-l’Alleud, Belgium, to PolyPeptide Laboratories Holding (PPL...
07.12.2016
- French drugs major Sanofi is weighing a rival offer to Johnson & Johnson’s recent bid for Swiss pharmaceuticals and biotech firm Actelion, the news agency Bloomberg has reported...
05.12.2016
- Anglo-Swedish drugmaker AstraZeneca is collaborating with Bicycle Therapeutics to develop a novel class of small-molecule medicines for treating respiratory, cardiovascular and...
30.11.2016
- The splash-making news that Swiss pharmaceuticals and biotechnology firm Actelion is holding preliminary talks with major US healthcare company Johnson & Johnson (J&J) about a...
24.11.2016
- Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...
21.11.2016
- More than 12,000 foreign companies have already chosen Hesse as the place to do business. A clear commitment to Europe’s most central location. Across all industries, employers...
14.11.2016
- Based on positions he took during the election campaign, the US pharmaceutical and biotech sectors stand to benefit from a Donald Trump presidency, some analysts have suggested. In...
10.11.2016
- Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The...
